gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · TAOXFinancialsBanking & Credit

Tao Synergies Inc. Common Stock (TAOX)

$2.67−0.37%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$2.68▼ 66.20% in range
Nov 3, 2025Low $2.52 · High $8.32Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Tao Synergies closed at $2.67 on Nov 4, down 0.37%, 67.9% below its 52-week closing high. Volume of 109.7K shares was 0.78× its 20-day average (below normal).

Split-adjusted performance: -41.4% over one month, -58.5% over six months, -66.3% over one year.

In the quarter ended Jun 30, 2026, revenue was $88.63K, with a net margin of -15410.8%.

Short interest was 549.2K shares at the Oct 15 settlement, down 20.3% from the prior report (7.6% of float, 3.0 days to cover).

Market cap$21.5M8.0M shares
Revenue · quarter$88.6K—
Diluted EPS$-1.83—
P/E · TTM—P/S 27.8×
Net margin-15,410.8%Gross 100.0%
Dividend yieldNone
52-week range2.52 – 8.32−67.9% from high
Volume109.7K0.78× 20-day avg
Volatility · 60d80.1%Annualised
Short % of float7.6%3.0 days to cover
Net cash$2.4MCash $2.4M
Next earnings—Not scheduled
Split-adjusted performance
1W −16.0%1M −41.4%3M −22.4%6M −58.5%YTD −27.4%1Y −66.3%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Banking & Credit

Percentile among 435 companies (100 = best)

6-month momentum3
Revenue growth—
Net margin1
Value (low P/E)—
Size4

Industry medians: 6-month return +7.4%, revenue growth +5.2%, net margin 18.2%, P/E 12.5×.

Short interest

Details →
Shares short549.2K−20.3% vs prior
Days to cover3.0Settled Oct 15
% of float7.6%
Short vol. 10d46.3%of daily volume

Closest peers by size in Banking & Credit

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
TAOXTao Synergies$2.67−0.37%−58.5%—−15410.8%—$21.5M
ATCHAtlasClear Holdings$0.1403+1.74%−44.7%+136.8%−37.4%10.9$21.3MCompare
VIPVulcan Infrastructure and Power$1.13−4.24%————$20.8MCompare
BLNEBeeline Holdings$0.6921−0.70%−67.2%+57.3%−155.1%—$22.8MCompare
MNSBPMainStreet Bancshares, Inc. Depositary Shares$23.00+1.59%−8.6%−6.7%12.5%1.5$23.0MCompare
BCGBinah Capital Group$1.16+9.43%−45.5%+11.8%−0.1%8.9$19.8MCompare
FRMEPFirst Merchants Corporation Depository Shares$24.92+0.69%−3.5%+12.8%22.5%0.1$24.9MCompare
DRKDarkHorse Technologies$1.72−7.28%————$18.2MCompare
FGCFG Communities Holdings$5.55+6.73%————$25.5MCompare

News about Tao Synergies

All news →

No recent articles focused on Tao Synergies.

Quick answers

What does Tao Synergies do?
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
What is TAOX's market cap?
$21.48M, based on the Nov 4 close of $2.67.
Does Tao Synergies pay a dividend?
No regular cash dividend has been paid in the last year.
How much of TAOX is sold short?
549.2K shares, 7.6% of float, as of Oct 15, 2026.
What sector is TAOX in?
Financials, in the Banking & Credit industry.

About Tao Synergies

TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.

HQ: New York, NY4 employeesListed Dec 7, 2020taosynergies.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology